MediPharm Labs Reports Stellar Financial Growth
(TSE:LABS) has released an update. MediPharm Labs, a leader in pharmaceutical-quality cannabis concentrates, has reported a si...
Stay updated with breaking news from Pharm Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(TSE:LABS) has released an update. MediPharm Labs, a leader in pharmaceutical-quality cannabis concentrates, has reported a si...
/PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized...
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products for the Brazilian medical cannabis market. MediPharm has already received GMP certifications from the US FDA, the European Union, and Australia's TGA, and holds a drug establishment license from Health Canada. The Brazilian medical cannabis market is projected to reach CAD380m (USD282m) by 2025, according to industry forecasts. MediPharm Labs, which already produces two medical cannabis ...
MediPharm Labs (OTCMKTS:MEDIF – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Institutional and Insider Ownership 75.9% of Lifecore Biomedical […]
TORONTO, Dec. 22, 2023 /PRNewswire/ - MediPharm Labs Corp. a pharmaceutical company specialized in precision-based cannabinoids, today announced an update regarding its Board of Directors and...